PMID- 2832964 OWN - NLM STAT- MEDLINE DCOM- 19880503 LR - 20061115 IS - 0340-6245 (Print) IS - 0340-6245 (Linking) VI - 58 IP - 4 DP - 1987 Dec 18 TI - Circulating activities during constant infusion of heparin or a low molecular weight derivative (enoxaparine): failure to demonstrate any circadian variations. PG - 1068-72 AB - We compared in six patients successively treated with an unfractionated heparin (UFH) and a low molecular weight heparin (LMWH) the variations in plasma anti-Xa activity, measured in a chromogenic assay, during a 36 h constant infusion. The values varied in a wider range during UHF infusion, but remained in the therapeutic range except once in one patient. No circadian rhythm could be demonstrated in our six patients. LMWH infusion yielded very constant anti-Xa circulating activities. In both cases, there were no significant modifications of three proteins with high heparin affinity (antithrombin III, heparin cofactor II, histidine-rich glycoprotein). Our results suggest that the circadian rhythm of the biological activities previously observed in patients treated with constant heparin infusion using clotting method is due to other factors than heparin itself. FAU - Toulon, P AU - Toulon P AD - Centre de Recherche Claude-Bernard sur les maladies vasculaires peripheriques et Hopital Broussais, Paris, France. FAU - Vitoux, J F AU - Vitoux JF FAU - Leroy, C AU - Leroy C FAU - Lecomte, T AU - Lecomte T FAU - Roncato, M AU - Roncato M FAU - Motobashi, Y AU - Motobashi Y FAU - Aiach, M AU - Aiach M FAU - Fiessinger, J N AU - Fiessinger JN LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Germany TA - Thromb Haemost JT - Thrombosis and haemostasis JID - 7608063 RN - 0 (Heparin, Low-Molecular-Weight) RN - 0 (Serine Proteinase Inhibitors) RN - 9005-49-6 (Heparin) RN - EC 3.4.21.6 (Factor Xa) SB - IM MH - Adult MH - Aged MH - Circadian Rhythm MH - Factor Xa MH - Heparin/*administration & dosage/blood MH - Heparin, Low-Molecular-Weight/*administration & dosage MH - Humans MH - Infusions, Intravenous MH - Male MH - Middle Aged MH - Serine Proteinase Inhibitors MH - Vascular Diseases/blood/drug therapy EDAT- 1987/12/18 00:00 MHDA- 1987/12/18 00:01 CRDT- 1987/12/18 00:00 PHST- 1987/12/18 00:00 [pubmed] PHST- 1987/12/18 00:01 [medline] PHST- 1987/12/18 00:00 [entrez] PST - ppublish SO - Thromb Haemost. 1987 Dec 18;58(4):1068-72.